Biomolecules & Therapeutics · 2012 · 54 citations · 23 references
Life SciencesOncologyPharmacologyApoptosisCancer PharmacologyCancer PreventionApoptosis In CancerApoptosis ModulationApoptosis RegulationApoptotic SignalingOncology PharmacologyAnticancer ActivityAntioxidant ChemopreventionApoptosis Signaling In CancerApoptotic Signaling In CancerCancer Cell Survival SignalingOxidative Stress In CancerPhytochemicals In Cancer PreventionPolyphenol Chemoprevention
Hesperidin, a flavanone present in citrus fruits, has been studied as potential therapeutic agents that have anti-tumor activity and apoptotic effects in several cancers, but there is no report about the apoptotic effect of hesperidin in human malignant pleural mesothelioma through the specificity protein 1 (Sp1) protein. We investigated whether hesperidin inhibited cell growth and regulated Sp1 target proteins by suppressing the levels of Sp1 protein in MSTO-211H cells. The IC50 value of hesperidin was determined to be 152.3 μM in MSTO-211H cells for 48 h. Our results suggested that hesperidin (0-160 μM) decreased cell viability, and induced apoptotic cell death. Hesperidin increased Sub-G1 population in MSTO-211H cells. Hesperidin significantly suppressed mRNA/protein level of Sp1 and modulated the expression level of the Sp1 regulatory protein such as p27, p21, cyclin D1, Mcl-1, and survivin in mesothelioma cells. Also, hesperidin induced apoptotic signaling including: cleavages of Bid, caspase-3, and PARP, upregulation of Bax, and down-regulation of Bcl-xl in mesothelioma cells. These results show that hesperidin suppressed mesothelioma cell growth through inhibition of Sp1. In this study, we demonstrated that Sp1 acts as a novel molecular target of hesperidin in human malignant pleural mesothelioma.
23
Flavonoid intake and risk of chronic diseases
Paul Knekt, Jorma Kumpulainen, Ritva Järvinen et al. · American Journal of Clinical Nutrition · 2002 · 1.8K citations
J.R. Dimmock, Dorothea Elias, Michael A. Beazely et al. · Current Medicinal Chemistry · 1999 · 593 citations
Ulla Justesen, Pia Knuthsen, Torben Leth · Journal of Chromatography A · 1998 · 549 citations
Rituximab: Mechanism of action and resistance
David G. Maloney, Barbara Smith, Andrea L. Rose · Seminars in Oncology · 2002 · 370 citations